GB0425766D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0425766D0
GB0425766D0 GBGB0425766.3A GB0425766A GB0425766D0 GB 0425766 D0 GB0425766 D0 GB 0425766D0 GB 0425766 A GB0425766 A GB 0425766A GB 0425766 D0 GB0425766 D0 GB 0425766D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0425766.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB0425766.3A priority Critical patent/GB0425766D0/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of GB0425766D0 publication Critical patent/GB0425766D0/en
Priority to US11/280,128 priority patent/US7122683B2/en
Priority to AP2007004003A priority patent/AP2007004003A0/en
Priority to KR1020077014351A priority patent/KR100886294B1/en
Priority to BRPI0518486-0A priority patent/BRPI0518486A2/en
Priority to CNA2005800401025A priority patent/CN101065355A/en
Priority to AU2005308534A priority patent/AU2005308534A1/en
Priority to JP2007542360A priority patent/JP4233596B2/en
Priority to EA200700920A priority patent/EA011217B1/en
Priority to EP05808510A priority patent/EP1817281A1/en
Priority to PCT/IB2005/003643 priority patent/WO2006056884A1/en
Priority to MX2007006138A priority patent/MX2007006138A/en
Priority to CA002589258A priority patent/CA2589258A1/en
Priority to PE2005001362A priority patent/PE20061056A1/en
Priority to ARP050104866A priority patent/AR052243A1/en
Priority to UY29224A priority patent/UY29224A1/en
Priority to TW094140922A priority patent/TWI300776B/en
Priority to GT200500337A priority patent/GT200500337A/en
Priority to NL1030485A priority patent/NL1030485C2/en
Priority to SV2005002311A priority patent/SV2006002311A/en
Priority to PA20058653501A priority patent/PA8653501A1/en
Priority to NL1032760A priority patent/NL1032760C2/en
Priority to IL183191A priority patent/IL183191A0/en
Priority to NO20072486A priority patent/NO20072486L/en
Priority to ZA200703910A priority patent/ZA200703910B/en
Priority to TNP2007000201A priority patent/TNSN07201A1/en
Priority to MA29935A priority patent/MA29038B1/en
Priority to CR9171A priority patent/CR9171A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
GBGB0425766.3A 2004-11-23 2004-11-23 Novel compounds Ceased GB0425766D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
GBGB0425766.3A GB0425766D0 (en) 2004-11-23 2004-11-23 Novel compounds
US11/280,128 US7122683B2 (en) 2004-11-23 2005-11-15 Amides useful as monoamine re-uptake inhibitors
CA002589258A CA2589258A1 (en) 2004-11-23 2005-11-18 N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors
BRPI0518486-0A BRPI0518486A2 (en) 2004-11-23 2005-11-18 new compounds
KR1020077014351A KR100886294B1 (en) 2004-11-23 2005-11-18 N-[3s-pyrrolidin-3-yl]-benzamide derivatives as monoamine re-uptake inhibitors
AP2007004003A AP2007004003A0 (en) 2004-11-23 2005-11-18 N-[(3S)-pyrrolidin-3YL]-benzamide derivatives as monoamine re-uptake inhibitors
CNA2005800401025A CN101065355A (en) 2004-11-23 2005-11-18 N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors
AU2005308534A AU2005308534A1 (en) 2004-11-23 2005-11-18 N- [ (3S)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors
JP2007542360A JP4233596B2 (en) 2004-11-23 2005-11-18 N- (3S) -pyrrolidin-3-yl-benzamide derivatives as monoamine reuptake inhibitors
EA200700920A EA011217B1 (en) 2004-11-23 2005-11-18 N-[(3s)-pyrrolidin-3-yl]-benzamide derivatives as monoamine re-uptake inhibitors
EP05808510A EP1817281A1 (en) 2004-11-23 2005-11-18 N- [(3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors
PCT/IB2005/003643 WO2006056884A1 (en) 2004-11-23 2005-11-18 N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors
MX2007006138A MX2007006138A (en) 2004-11-23 2005-11-18 N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors.
PE2005001362A PE20061056A1 (en) 2004-11-23 2005-11-21 DERIVATIVES OF N - [(3S) -PYRROLIDIN-3-IL] -BENZAMIDE AS INHIBITORS OF THE RECAPTATION OF SEROTONIN AND / OR NORADRENALINE
ARP050104866A AR052243A1 (en) 2004-11-23 2005-11-21 DERIVATIVES OF N - [(3S) -PIRROLIDIN-3-IL] -BENZAMIDA, USEFUL AS INHIBITORS OF MONOAMINE RECAPTATION
NL1030485A NL1030485C2 (en) 2004-11-23 2005-11-22 New connections.
UY29224A UY29224A1 (en) 2004-11-23 2005-11-22 SUBSTITUTED DERIVATIVES OF N - ((3S) -PIRROLIDIN-3IL) BENZAMIDA, COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
TW094140922A TWI300776B (en) 2004-11-23 2005-11-22 Novel compounds
GT200500337A GT200500337A (en) 2004-11-23 2005-11-22 NEW COMPOUNDS
SV2005002311A SV2006002311A (en) 2004-11-23 2005-11-23 NEW COMPOUNDS REF. PC32649A
PA20058653501A PA8653501A1 (en) 2004-11-23 2005-11-23 NEW COMPOUNDS
NL1032760A NL1032760C2 (en) 2004-11-23 2006-10-27 New connections.
IL183191A IL183191A0 (en) 2004-11-23 2007-05-14 N-[(3s)-pyrrolidin-3-yl]-benzamide derivatives as monoamine re-uptake inhibitors
NO20072486A NO20072486L (en) 2004-11-23 2007-05-15 N - [(3S) -pyrrolidin-2-yl] benzamide derivatives as monoamine reuptake inhibitors
ZA200703910A ZA200703910B (en) 2004-11-23 2007-05-15 N-[(3S)-pyrrolidin-3YL]-benzamide derivatives as monoamine re-uptake inhibitors
TNP2007000201A TNSN07201A1 (en) 2004-11-23 2007-05-22 N- [(3S)] PYRROLIDINE -3-YL] BENZAMIDE DERIVATIVES AS INHIBITORS OF REABSORPTION OF MONOAMINES
MA29935A MA29038B1 (en) 2004-11-23 2007-05-23 N - [(3S) -PYRROLIDIN-3-YL] -BENZAMIDE DERIVATIVES AS INHIBITORS OF REABSORPTION OF MONOAMINES
CR9171A CR9171A (en) 2004-11-23 2007-06-07 NEW COMPOUNDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0425766.3A GB0425766D0 (en) 2004-11-23 2004-11-23 Novel compounds

Publications (1)

Publication Number Publication Date
GB0425766D0 true GB0425766D0 (en) 2004-12-22

Family

ID=33548739

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0425766.3A Ceased GB0425766D0 (en) 2004-11-23 2004-11-23 Novel compounds

Country Status (26)

Country Link
EP (1) EP1817281A1 (en)
JP (1) JP4233596B2 (en)
KR (1) KR100886294B1 (en)
CN (1) CN101065355A (en)
AP (1) AP2007004003A0 (en)
AR (1) AR052243A1 (en)
AU (1) AU2005308534A1 (en)
BR (1) BRPI0518486A2 (en)
CA (1) CA2589258A1 (en)
CR (1) CR9171A (en)
EA (1) EA011217B1 (en)
GB (1) GB0425766D0 (en)
GT (1) GT200500337A (en)
IL (1) IL183191A0 (en)
MA (1) MA29038B1 (en)
MX (1) MX2007006138A (en)
NL (2) NL1030485C2 (en)
NO (1) NO20072486L (en)
PA (1) PA8653501A1 (en)
PE (1) PE20061056A1 (en)
SV (1) SV2006002311A (en)
TN (1) TNSN07201A1 (en)
TW (1) TWI300776B (en)
UY (1) UY29224A1 (en)
WO (1) WO2006056884A1 (en)
ZA (1) ZA200703910B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH628885A5 (en) * 1978-01-01 1982-03-31 Anphar Sa Piperidine derivative
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors
CA2530159C (en) * 2003-06-17 2010-02-02 Pfizer Inc. N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors

Also Published As

Publication number Publication date
NL1032760A1 (en) 2006-12-13
MX2007006138A (en) 2007-07-19
CR9171A (en) 2007-07-04
CA2589258A1 (en) 2006-06-01
UY29224A1 (en) 2006-06-30
JP4233596B2 (en) 2009-03-04
PE20061056A1 (en) 2006-11-08
EA200700920A1 (en) 2007-12-28
WO2006056884A1 (en) 2006-06-01
PA8653501A1 (en) 2006-06-02
MA29038B1 (en) 2007-11-01
TWI300776B (en) 2008-09-11
SV2006002311A (en) 2006-09-14
GT200500337A (en) 2006-06-13
ZA200703910B (en) 2008-09-25
AR052243A1 (en) 2007-03-07
NL1030485C2 (en) 2006-11-07
IL183191A0 (en) 2007-08-19
KR100886294B1 (en) 2009-03-04
CN101065355A (en) 2007-10-31
AP2007004003A0 (en) 2007-06-30
NO20072486L (en) 2007-06-20
TW200626543A (en) 2006-08-01
AU2005308534A1 (en) 2006-06-01
JP2008520646A (en) 2008-06-19
NL1030485A1 (en) 2006-05-24
BRPI0518486A2 (en) 2008-11-18
TNSN07201A1 (en) 2008-11-21
EP1817281A1 (en) 2007-08-15
EA011217B1 (en) 2009-02-27
NL1032760C2 (en) 2007-04-17
KR20070086599A (en) 2007-08-27

Similar Documents

Publication Publication Date Title
EP1718638A4 (en) Novel compounds
GB0400812D0 (en) Novel compounds
GB0409744D0 (en) Novel compounds
GB0405628D0 (en) Novel compounds
GB0402140D0 (en) Novel compounds
GB0402496D0 (en) Novel compounds
EP1805132A4 (en) Novel compounds
EP1796793A4 (en) Novel compounds
GB0402357D0 (en) Novel compounds
GB0408083D0 (en) Novel compounds
GB0402355D0 (en) Novel compounds
GB0402812D0 (en) Novel compounds
GB0402356D0 (en) Novel compounds
GB0404105D0 (en) Novel compounds
GB0402380D0 (en) Novel compounds
GB0408448D0 (en) Novel compounds
GB0406027D0 (en) Novel compounds
GB0400699D0 (en) Novel compounds
GB0400901D0 (en) Novel compounds
GB0406031D0 (en) Novel compounds
GB0401727D0 (en) Novel compounds
GB0406030D0 (en) Novel compounds
GB0402110D0 (en) Novel compounds
GB0402114D0 (en) Novel compounds
GB0408984D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)